Search company, investor...


Founded Year



Unattributed - III | Alive

Total Raised


Last Raised

$130K | 5 yrs ago

About Celsense

Celsense is a biotechnology company offering MRI agents that allow scientists and clinicians to monitor the location and quantity of transplanted cells. The company's products have application in the fields of regenerative medicine, immunotherapy, and the study of inflammation and immune system response. Celsense is currently collaborating with pharmaceutical and biotechnology organizations and is developing products suitable for human use.

Headquarters Location

603 Stanwix Street Suite 390

Pittsburgh, Pennsylvania, 15222,

United States


Missing: Celsense's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Celsense's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing Celsense

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

Celsense is included in 5 Expert Collections, including Regenerative Medicine.


Regenerative Medicine

1,818 items

Regenerative medicine refers to the process of activating, replacing, engineering or regenerating human genetic material, cells, tissues or organs to restore normal function. It also includes bioengineered tissues used for in vitro testing (e.g. organ-on-a-chip, organoids).


Medical Devices

8,562 items

Companies developing medical devices (per the IMDRF's definition of "medical device"). Includes software, lab-developed tests (LDTs), and combination products. *Columns updated as regularly as possible.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.


Health Monitoring & Diagnostics

2,535 items

Companies developing or offering products that aid in the assessment, screening, diagnosis, or monitoring of a person's state of health/wellness. Excludes companies focused solely on fitness/sports performance


Health IT

7,901 items

Celsense Patents

Celsense has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Immunology, Nuclear magnetic resonance, Cell biology, Transcription factors, Biotechnology


Application Date


Grant Date



Related Topics

Immunology, Nuclear magnetic resonance, Cell biology, Transcription factors, Biotechnology



Latest Celsense News

Celsense Inc Pharmaceuticals Healthcare Deals and Alliances Profile Report Updated 13082018 Prices from USD $250

Oct 12, 2018

13:55 EDT 12 Oct 2018 | BioPortfolio Reports Summary Celsense Inc Celsense is a biotechnology company that develops magnetic resonance imaging detection products to monitor the location and quantity of transplanted cells. The company's products include vsense, cell sense and voxel tracker. Its vsense product is a reagent used to detect various lesions and diseases such as cancer, cardiovascular disease, autoimmune disease, infectious pathogens, and injury. Celsense offers developing cell labeling protocols, validation studies, imaging experimental design, and study management services. The company's products are used for inflammation and transplanted cells for therapeutic and diagnostic applications. Celsense is headquartered in Pittsburgh, Pennsylvania, the US. Celsense Inc Pharmaceuticals Healthcare Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions MAs, partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, subsector and regions. GlobalData derived the data presented in this report from proprietary inhouse Pharma eTrack deals database, and primary and secondary research. Scope Financial Deals Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships. Deals by Year Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period. Deals by Type Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc. Deals by Region Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America. Deals by Subsector Chart and table showing information on the number of deals and value reported by the company, by subsector. Major Deals Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's major public companies key financial metrics and ratios. Business Description A brief description of the company's operations. Key Employees A list of the key executives of the company. Important Locations and Subsidiaries A list and contact details of key centers of operation and subsidiaries of the company. Key Competitors A list of the key competitors of the company. Key Recent Developments A brief on recent news about the company. Reasons to Buy Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period. Understand the company's business segments' expansion / divestiture strategy The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy. Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company's key financial metrics and ratios. Equip yourself with detailed information about the company's operations to identify potential customers and suppliers. The profile analyzes the company's business structure, locations and subsidiaries, key executives and key competitors. Stay uptodate on the major developments affecting the company Recent developments concerning the company presented in the profile help you track important events. Gain key insights into the company for academic or business research Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs. Note*: Some sections may be missing if data is unavailable for the company. Related Biotechnology, Pharmaceutical and Healthcare News

Celsense Web Traffic

Page Views per User (PVPU)
Page Views per Million (PVPM)
Reach per Million (RPM)
CBI Logo

Celsense Rank

Celsense Frequently Asked Questions (FAQ)

  • When was Celsense founded?

    Celsense was founded in 2005.

  • Where is Celsense's headquarters?

    Celsense's headquarters is located at 603 Stanwix Street, Pittsburgh.

  • What is Celsense's latest funding round?

    Celsense's latest funding round is Unattributed - III.

  • How much did Celsense raise?

    Celsense raised a total of $2.61M.

  • Who are the investors of Celsense?

    Investors of Celsense include LaunchCyte and Pittsburgh Life Sciences Greenhouse.

  • Who are Celsense's competitors?

    Competitors of Celsense include Axion BioSystems, iMMCO Diagnostics, Mercator MedSystems, Cytox, Affinergy and 13 more.

Compare Celsense to Competitors


BMDSys develops, produces, sells and services non-invasive, contact-free cardiac diagnostic imaging systems using extremely high sensitive magnetic sensors. It does not expose the patient to any X-Rays, magnetic field or any other kind

Cellatope Corporation

Cellatope is a cell analysis company that is developing research and diagnostic products and services in the field of autoimmune and inflammatory disease, with an initial focus on lupus and transplant medicine.

LifeLineLab S.r.l.

Lifelinelab s.r.l. started its activities in April 2003, thanks to the commitment of three managers coming from the ex Diagnostic Division Manufacturing Plant of Alfa Wassermann S.P.A. First step has been to secure raw materials, and equipment for R&D and Manufacturing of products and services in the field of Human in Vitro Diagnostics. nnnnnFirst diagnostic reagents were manufactured, in this site, over 40 years ago, through the bravery and the enterprising spirit of Prof. Balducci ex Managing Director of Virology Laboratory of "Istituto Superiore di Sanitu00e0". First products were based on tissue colture technology included a line of complement fixation antigens. Since then, the company developed methods and products, covering almost all the fields of Human in Vitro Diagnostics, from Clinical Chemistry to Immunochemistry. The mostly developed sector has been that of Infectious Diseases with particular regard to Viral pathologies. Most products have been developed using biological raw materials derived from in house, in vivo or in vitro, productions. Nowadays the company aims to face and develop markets with consolidate and emerging technologies such as Microarrays using a chemistry patented and designed to covalently bind either Protein or Nucleic acids which aims to allow the development of extremely sophisticated analysis in the emerging applications of proteomics and genomics.


G-Nostics is a company in the field of personalised medicine based on the science of pharmacogenetics. The initial product is a diagnostic test, the NicoTest, focused on targeting treatment to aid smoking cessation.

PetsDx Imaging

PetsDx Veterinary Imaging, Inc. is engaged in veterinary medicine and magnetic resonance imaging (MRI). PetsDX works with local veterinarians.

Orthoscan Logo

OrthoScan, Inc. manufactures the OrthoScan High Definition Mini C-Arm for extremity imaging. Designed for orthopedic surgeons, the small, lightweight C-arm configuration fluoroscopic system aims to provide real-time images with four times the resolution of other currently available fluoroscans. It can be used during surgical orthopedic procedures, and critical and emergency care procedures.OrthoScan, headquartered in Scottsdale, Arizona, uses state-of-the-art technologies to bring x-ray imaging in extremity surgery to a next level. For instance, innovative flat detectors in the latest product introduction named OrthoScan HD, allows reduction of distortions inherent with previous image intensifier technology, thereby improving significantly diagnostic accuracy. The mini C-Arms by OrthoScan provide the solution needed by orthopaedics and podiatrists for high-quality imaging in a small-scale device, facilitating complex surgeries on small and delicate body structures, such as wrists, knees and ankles. In September 2011, Orthoscan was acquired Aton, a German private investment firm. Orthoscan's valuation was not disclosed.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.